Подписаться
Lipika Chablani
Lipika Chablani
St. John Fisher University
Подтвержден адрес электронной почты в домене sjf.edu - Главная страница
Название
Процитировано
Процитировано
Год
Inline real-time near-infrared granule moisture measurements of a continuous granulation–drying–milling process
L Chablani, MK Taylor, A Mehrotra, P Rameas, WC Stagner
Aaps PharmSciTech 12, 1050-1055, 2011
982011
Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension
HI Shahin, BP Vinjamuri, AA Mahmoud, RN Shamma, SM Mansour, ...
Journal of Controlled Release 302, 126-139, 2019
672019
Evaluation of microparticulate ovarian cancer vaccine via transdermal route of delivery
SA Tawde, L Chablani, A Akalkotkar, MJ D'Souza
Journal of Controlled Release 235, 147-154, 2016
592016
Spray-dried microparticles: a potential vehicle for oral delivery of vaccines
L Chablani, SA Tawde, MJ D'souza
Journal of microencapsulation 29 (4), 388-397, 2012
502012
Formulation and evaluation of oral microparticulate ovarian cancer vaccines
SA Tawde, L Chablani, A Akalkotkar, C D'Souza, M Chiriva-Internati, ...
Vaccine 30 (38), 5675-5681, 2012
352012
Evaluation of a Particulate Breast Cancer Vaccine Delivered via Skin
L Chablani, SA Tawde, A Akalkotkar, MJ D’Souza
The AAPS Journal 21, 1-11, 2019
342019
Formulation and evaluation of a particulate oral breast cancer vaccine
L Chablani, SA Tawde, A Akalkotkar, C D'Souza, P Selvaraj, MJ D'Souza
Journal of pharmaceutical sciences 101 (10), 3661-3671, 2012
342012
A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications
HI Shahin, L Chablani
Journal of Drug Delivery Science and Technology 84, 104553, 2023
262023
Formulation and optimization of sildenafil citrate-loaded PLGA large porous microparticles using spray freeze-drying technique: a factorial design and in-vivo pharmacokinetic study
H Shahin, BP Vinjamuri, AA Mahmoud, SM Mansour, MB Chougule, ...
International Journal of Pharmaceutics 597, 120320, 2021
262021
Basics of compounding: vehicles for compounded oral liquid medications: a review
K Cutaia, L Chablani, F Zhao
International Journal of Pharmaceutical Compounding 22 (6), 480, 2018
252018
Examining the bleeding incidences associated with targeted therapies used in metastatic renal cell carcinoma
MK Crist, E Hansen, L Chablani, E Guancial
Critical Reviews in Oncology/Hematology 120, 151-162, 2017
232017
Oral delivery of particulate prostate cancer vaccine: In vitro and in vivo evaluation
A Akalkotkar, SA Tawde, L Chablani, MJ D’Souza
Journal of drug targeting 20 (4), 338-346, 2012
232012
Development and optimization of paclitaxel loaded Eudragit/PLGA nanoparticles by simplex lattice mixture design: Exploration of improved hemocompatibility and in vivo kinetics
G Jeswani, L Chablani, U Gupta, RK Sahoo, KT Nakhate
Biomedicine & Pharmacotherapy 144, 112286, 2021
192021
Development of a microparticulate prostate cancer vaccine and evaluating the effect of route of administration on its efficacy via the skin
A Akalkotkar, L Chablani, SA Tawde, C D’Souza, MJ D’Souza
Journal of microencapsulation 32 (3), 281-289, 2015
172015
Cell-penetrating peptides as passive permeation enhancers for transdermal drug delivery
L Chablani, V Singh
Aaps Pharmscitech 23 (7), 266, 2022
152022
A comparison of cancer vaccine adjuvants in clinical trials
M Marriott, B Post, L Chablani
Cancer Treatment and Research Communications 34, 100667, 2023
132023
The use of podcast as a teaching tool for a pharmacy compounding pre-laboratory lecture: A survey based study
L Kratochwill, E Almagambetova, A Corigliano, CR Birnie PhD, ...
Pharmacy Education 16 (1), 37, 2016
122016
Exploration of hemocompatibility and intratumoral accumulation of paclitaxel after loco-regional administration of thermoresponsive hydrogel composed of poloxamer and xanthan …
G Jeswani, L Chablani, U Gupta, RK Sahoo, KT Nakhate, AG Taksande
International Journal of Biological Macromolecules 226, 746-759, 2023
112023
Immunotherapy as a second-line or later treatment modality for advanced non-small cell lung cancer: A review of safety and efficacy
E Geraci, L Chablani
Critical Reviews in Oncology/Hematology 152, 103009, 2020
112020
Safety and toxicity counts of nanocosmetics
G Jeswani, S Das Paul, L Chablani, Ajazuddin
Nanocosmetics: From Ideas to Products, 299-335, 2019
92019
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20